Terminated trial tests new weapon against tough head & neck cancers
NCT ID NCT06046482
Summary
This study aimed to see if adding an experimental drug called magrolimab to standard cancer treatments could help control advanced head and neck cancer that had returned or spread. It was designed for adults whose cancer had progressed despite prior therapy. The trial was terminated early after enrolling only 4 participants, so no results are available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD NECK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.